PFIZER INC (PFE) Share buybacks
- Total buybacks · last 12 months (USD): Value $0.00; Formula and calculation Trailing-year cash paid for share repurchases. Period ending 2024-12-31..
- Buyback yield · 12 months: Value (m); Formula and calculation Cash paid for share repurchases / current market cap. Period ending 2024-12-31..
Share buybacks
Overview →Financial period ending 2024-12-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total buybacks · last 12 months (USD) | $0.00 | Trailing-year cash paid for share repurchases. Period ending 2024-12-31. |
| Buyback yield · 12 months | (m) | Cash paid for share repurchases / current market cap. Period ending 2024-12-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Buybacks · 12 months | 0.00 USD | Payments for Repurchase of Common Stock |
| Market cap | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total buybacks | Market cap (USD) | Buyback yield |
|---|---|---|---|
| 2024-12-31 | $0.00 | (m) | (m) |
| 2023-12-31 | $0.00 | (m) | (m) |
| 2023-10-01 | $0.00 | (m) | (m) |
| 2023-07-02 | $0.00 | (m) | (m) |
| 2023-04-02 | $0.00 | (m) | (m) |
| 2022-12-31 | $2.00B | (m) | (m) |
| 2022-10-02 | $2.00B | (m) | (m) |
| 2022-07-03 | $2.00B | (m) | (m) |
| 2022-04-03 | $2.00B | (m) | (m) |
| 2021-12-31 | $0.00 | (m) | (m) |
| 2021-10-03 | $0.00 | (m) | (m) |
| 2021-07-04 | $0.00 | (m) | (m) |
| 2021-04-04 | $0.00 | (m) | (m) |
| 2020-12-31 | $0.00 | (m) | (m) |
| 2020-09-27 | $0.00 | (m) | (m) |
| 2020-06-28 | $0.00 | (m) | (m) |
| 2020-03-29 | $0.00 | (m) | (m) |
| 2019-12-31 | $8.87B | (m) | (m) |
| 2019-09-29 | $13.89B | (m) | (m) |
| 2019-06-30 | $15.00B | (m) | (m) |
| 2019-03-31 | $15.00B | (m) | (m) |
| 2018-12-31 | $12.20B | (m) | (m) |
| 2018-09-30 | $7.17B | (m) | (m) |
| 2018-07-01 | $6.06B | (m) | (m) |
| 2018-04-01 | $6.06B | (m) | (m) |
| 2017-12-31 | $5.00B | (m) | (m) |
| 2017-10-01 | $5.00B | (m) | (m) |
| 2017-07-02 | $5.00B | (m) | (m) |
| 2017-04-02 | $5.00B | (m) | (m) |
| 2016-12-31 | $5.00B | (m) | (m) |
| 2016-10-02 | $5.00B | (m) | (m) |
| 2016-07-03 | $5.16B | (m) | (m) |
| 2016-04-03 | $5.16B | (m) | (m) |
| 2015-12-31 | $6.16B | (m) | (m) |
| 2015-09-27 | $7.36B | (m) | (m) |
| 2015-07-13 | (m) | (m) | (m) |
| 2015-06-28 | $8.48B | (m) | (m) |
| 2015-03-29 | $9.80B | (m) | (m) |
| 2014-12-31 | $5.00B | (m) | (m) |
| 2014-09-28 | $8.45B | (m) | (m) |
| 2014-06-29 | $10.92B | (m) | (m) |
| 2014-03-30 | $12.86B | (m) | (m) |
| 2013-12-31 | $16.29B | (m) | (m) |
| 2013-09-29 | $15.04B | (m) | (m) |
| 2013-06-30 | $13.12B | (m) | (m) |
| 2013-03-31 | $11.20B | (m) | (m) |
| 2012-12-31 | $8.23B | (m) | (m) |
| 2012-09-30 | $8.04B | (m) | (m) |
| 2012-07-01 | $8.32B | (m) | (m) |
| 2012-04-01 | $9.23B | (m) | (m) |
| 2011-12-31 | $9.00B | (m) | (m) |
| 2011-10-02 | $5.79B | (m) | (m) |
| 2011-07-03 | $4.18B | (m) | (m) |
| 2011-04-03 | (m) | (m) | (m) |
| 2010-12-31 | $1.00B | (m) | (m) |
| 2010-10-03 | $1.00B | (m) | (m) |
| 2010-07-04 | $500.00M | (m) | (m) |
| 2009-12-31 | $0.00 | (m) | (m) |
| 2009-09-27 | (m) | (m) | (m) |
| 2009-06-28 | (m) | (m) | (m) |
| 2008-12-31 | $500.00M | (m) | (m) |
| 2008-09-28 | (m) | (m) | (m) |
| 2008-06-29 | (m) | (m) | (m) |
| 2007-12-31 | $9.99B | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |